WH
WHCE.LSE Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc
- USD
No recent price
- Total assets
- 74.9M
- Expense ratio
- 0.19%
- Dividend yield
- -
- 1-year return
- +25.35%
- Holdings
- 66
- Since
- 2023
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does WHCE.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (73.8%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (73.3%)
- Top 3 holdings: 38.6% of the fund
Asset allocation
- US stocks 73.8%
- Non-US stocks 26.8%
- Cash 0.0%
Top holdings
- Eli Lilly and Company 18.87%
- AbbVie Inc 12.64%
- Merck & Company Inc 7.13%
- AstraZeneca PLC 4.93%
- Gilead Sciences Inc 4.72%
Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc performance
Sharpe ratio 0.69- This year
- +15.77%
- 1 year
- +25.35%
- 3 years
- +13.16%
- 5 years
- 0.00%
Volatility 19.0% over 1 year and 14.3% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
WHCE.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc top holdings
69.1% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 18.87% |
| AbbVie Inc ABBV.US | Healthcare | United States | 12.64% |
| Merck & Company Inc MRK.US | Healthcare | United States | 7.13% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 4.93% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 4.72% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 4.72% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 4.67% |
| Amgen Inc AMGN.US | Healthcare | United States | 4.21% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 3.73% |
| Abbott Laboratories ABT.US | Healthcare | United States | 3.52% |
The 10 largest of 66 holdings.
WHCE.LSE sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
WHCE.LSE regional exposure
- North America73.3%
- Europe Developed14.6%
- United Kingdom5.9%
- Japan4.0%
- Australasia1.4%
- Africa/Middle East0.5%
Share of the stocks in the fund.
Company size
Average market cap 243B- Mega cap36.5%
- Big cap55.2%
- Medium cap8.6%
- Small cap0.2%
Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc fund profile
- Fund name
- Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc
- Ticker
- WHCE.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Apr 12, 2023
- Trading currency
- USD
- Expense ratio
- 0.19%